Subscribe

Edward S. Kim, MD, FACP

Articles by Edward S. Kim, MD, FACP

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors

ByKathryn F. Mileham, MD, FACP,Mufti N. Ahmad, MD, FACP,Edward S. Kim, MD, FACP

April 15th 2019

In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.

Latest Updated Articles

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors
Published: April 15th 2019 | Updated:

Trending on CGTlive®

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again

FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss

© 2025 MJH Life Sciences^®

All rights reserved.